These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3875554)

  • 1. A short term follow up study on non-specific modulation of CMI by levamisole in advanced breast cancer.
    Saha K; Madan R; Kapila H; Shinghal RN
    Indian J Med Res; 1985 May; 81():499-507. PubMed ID: 3875554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
    Sansoni P; Rossetti A; Valente G; Butturini U
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
    Basch CM; Spitler LE; Engleman EG; Engleman EP
    J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI; Lukach EV; Krivokhatskaia LD
    Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic reactivity of breast cancer patients].
    Semiglazov VF; Kondrat'ev VB; Mar'enko AI; L'vovich EG; Sofronov BN
    Vopr Onkol; 1978; 24(8):74-9. PubMed ID: 695430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity in early human breast carcinoma.
    Conesa LC; Pasqualini RS; Pujato D; Lynch M
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(4):355-61. PubMed ID: 387244
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
    de Carli HO; Llargues JM
    Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of the administration of levamisole on the reactivity of T-lymphocytes in advanced cancer patients].
    Renoux G; Renoux M
    Nouv Presse Med; 1976 Jan; 5(2):67-70. PubMed ID: 772602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
    Klefström P
    Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of levamisole on cell-mediated immune responses in patients with nasopharyngeal carcinoma.
    Goh EH; Chan SH; Simons MJ
    IARC Sci Publ (1971); 1978; (20):503-10. PubMed ID: 730200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study.
    Yagnik CS; Jogaikar DG; Mehta JM
    Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses.
    Kundu SK; Hazra SK; Chaudhuri SK; Nandy A
    Indian J Lepr; 1985; 57(1):37-57. PubMed ID: 3839826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity & prognosis of human mammary carcinoma.
    Abrol SK; Shinghal RN; Saha K
    Indian J Med Res; 1984 Feb; 79():199-206. PubMed ID: 6611308
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of levamisole treatment in old people.
    Rossi ER; Librace E; Barocci S
    Boll Soc Ital Biol Sper; 1981 Jan; 57(2):202-6. PubMed ID: 7236393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [State of immunological reactivity in breast cancer patients receiving prednisolone treatment].
    Tsyrlina EV; Fedorov SN; Poroshina TE; Buslaeva VP; Seleznev IK
    Vopr Onkol; 1979; 25(5):60-2. PubMed ID: 462856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.